Viewing Study NCT02668666


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2026-02-02 @ 10:08 PM
Study NCT ID: NCT02668666
Status: COMPLETED
Last Update Posted: 2024-07-29
First Post: 2016-01-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Sponsor: Oana Danciu, MD
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-02-01
Start Date Type: ACTUAL
Primary Completion Date: 2023-07-03
Primary Completion Date Type: ACTUAL
Completion Date: 2023-10-24
Completion Date Type: ACTUAL
First Submit Date: 2016-01-27
First Submit QC Date: None
Study First Post Date: 2016-01-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-07-01
Results First Submit QC Date: None
Results First Post Date: 2024-07-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-25
Last Update Post Date: 2024-07-29
Last Update Post Date Type: ACTUAL